Who has invested in Apimeds Pharmaceuticals?

No investors are named on the public record for Apimeds Pharmaceuticals yet.

Apimeds Pharmaceuticals Funding: $100M Raised, Growth

Apimeds Pharmaceuticals funding overview

Apimeds Pharmaceuticals has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Growth.

Apimeds Pharmaceuticals at a glance

Total raised: $100M
Latest round: Growth

Frequently asked about Apimeds Pharmaceuticals funding

How much has Apimeds Pharmaceuticals raised?: Apimeds Pharmaceuticals has raised $100M in total disclosed funding across the rounds on record.
Who has invested in Apimeds Pharmaceuticals?: No investors are named on the public record for Apimeds Pharmaceuticals yet.
What was the latest Apimeds Pharmaceuticals funding round?: The most recent disclosed round is a Growth.
Where is Apimeds Pharmaceuticals based?: No headquarters location is disclosed for Apimeds Pharmaceuticals.

Round data for Apimeds Pharmaceuticals is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies and backer lists below.

Apimeds Pharmaceuticals Funding: $100M Raised, Growth

Apimeds Pharmaceuticals funding overview

Apimeds Pharmaceuticals at a glance

Frequently asked about Apimeds Pharmaceuticals funding

Companies related to Apimeds Pharmaceuticals (30)

Browse related funding lists (2)